Dr Culleton is Chief Executive Officer of ProKidney, a clinical-stage biotechnology company with a transformative proprietary cell therapy platform with the potential for treating Chronic Kidney Disease using a patient’s own cells. Previously, he was Vice President and Chief Medical Officer at CVS Kidney Care. Before joining CVS Heath, he was Vice President Global Clinical Development and World Wide Vice President, Medical Affairs, Medication and Procedural Solutions at Becton Dickinson, and previously Vice President, Renal Therapeutic Area at Baxter Healthcare. Prior to beginning his industry career in 2007, Dr Culleton was a Clinical Associate Professor, Department of Medicine at the University of Calgary. Dr Culleton holds a Bachelor’s degree in Medical Science and a Doctor of Medicine degree from the Memorial University of Newfoundland, and a Master’s degree in Business Administration from Northwestern University Kellogg School of Management. He completed a specialization in Internal Medicine and Nephrology through the Royal College of Physicians and Surgeons of Canada, as well as a fellowship in Clinical Epidemiology at Boston University, Framingham Heart Study.